Sign in
4

Changes in Ownership

KIORA PHARMACEUTICALS INC Filed Acc 0001144204-16-096682

Options or other derivatives

  • Chief Financial Officer acquired 41,732 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Brenneman Ryan Randall · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-04-25 Grant or award : show line 1 in the form Stock Option (right to buy) +41,732 $3.23 2026-04-25 41,732 41,732 D
Loading xslF345X03/v438134_4.xml…